Company research
Revium Rx.
CIK 1839140Updated Sep 24, 2026
SecurityRVRC · OTC · equity
RVRC price & chart
Loading TradingView…
OTC:RVRC on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
10-Q filing
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02
10-Q filing
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02, 9.01
Financials
FY 2025 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 |
|---|---|---|
| ASSETS | ||
| AssetsUSD | 8,296,000Source | 20,282,000Source |
| Property, Plant and Equipment, NetUSD | 10,000Source | 9,000Source |
| GoodwillUSD | 2,575,000Source | 11,414,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 2,497,000Source | 3,342,000Source |
| Current assets: | ||
| Cash and Cash Equivalents, at Carrying ValueUSD | 1,678,000Source | 3,268,000Source |
| Assets, CurrentUSD | 3,095,000Source | 5,517,000Source |
| Operating Lease, Right-of-Use AssetUSD | 119,000Source | — |
| LIABILITIES AND EQUITY | ||
| LiabilitiesUSD | 1,415,000Source | 576,000Source |
| Stockholders’ equity: | ||
| Common Stock, Value, IssuedUSD | 61,000Source | 61,000Source |
| Additional Paid in CapitalUSD | 31,782,000Source | 30,388,000Source |
| Retained Earnings (Accumulated Deficit)USD | -24,962,000Source | -11,513,000Source |
| Liabilities and EquityUSD | 8,296,000Source | 20,282,000Source |
| Current liabilities: | ||
| Liabilities, CurrentUSD | 1,369,000Source | 576,000Source |
| Operating Lease, Liability, CurrentUSD | 55,000Source | — |
| Accounts Payable, CurrentUSD | 163,000Source | 142,000Source |
| Operating Lease, Liability, NoncurrentUSD | 46,000Source | — |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | — | 770,000Source |
| Additional Financial Items | ||
| Accrued Liabilities, CurrentUSD | 461,000Source | 153,000Source |
cash flow · annual statements
| Line item | FY 2025 |
|---|---|
| Additional Financial Items | |
| Share-based Payment Arrangement, ExpenseUSD | 624,000Source |
| GoodwillUSD | 2,575,000Source |
| Goodwill, Impairment LossUSD | 8,839,000Source |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)USD | -845,000Source |
| Income Tax Expense (Benefit)USD | 358,000Source |
| Net Income (Loss) Attributable to ParentUSD | -13,449,000Source |
income statement · annual statements
| Line item | FY 2025 |
|---|---|
| Income Tax Expense (Benefit)USD | 358,000Source |
| Net Income (Loss) Attributable to ParentUSD | -13,449,000Source |
| Earnings Per Share, BasicUSD per share | -0.22Source |
| Earnings Per Share, DilutedUSD per share | -0.22Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 60,729,100Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 60,729,100Source |
| Additional Financial Items | |
| Goodwill, Impairment LossUSD | 8,839,000Source |